文献速递皮肤肿瘤

多发性聚集黄白色小球与非色素性基底细胞癌的相关性

Association of Multiple Aggregated Yellow-White Globules With Nonpigmented Basal Cell Carcinoma.
PubMed 文献 · JAMA Dermatol · 2020-01-01

这项回顾性病例对照研究纳入656个非色素性皮损,评估多发性聚集黄白色小球(MAY小球)对基底细胞癌(BCC)的诊断价值。MAY小球在21.0%的BCC中可见,仅0.8%的其他诊断中可见(P < .001),诊断BCC的比值比为32.0(96% CI, 9.9-103.2),且与组织学高危BCC相关(比值比6.5;95% CI, 3.1-14.3)。

要点

  • MAY小球对非色素性BCC诊断特异性高,比值比32.0。
  • MAY小球与组织学高危BCC亚型正相关,比值比6.5。
  • MAY小球在浅表型BCC中从未出现。

核心结论

  • MAY小球可能作为新的BCC皮肤镜诊断标准,具有高特异性。
  • MAY小球与浅表型BCC负相关,与深部、组织学更高级别亚型正相关。

研究设计与样本

  • 共纳入643例患者的656个非色素性皮损,平均年龄63.1岁(SD 14.9),男性381例(58.1%)。
  • 部分肿瘤进行前瞻性诊断,并行反射共聚焦显微镜、光学相干断层扫描和组织病理学对照。

主要发现

  • 291个(44.4%)皮损为BCC,194个(29.6%)位于头颈部。
  • MAY小球见于61/291例BCC(21.0%)和3/365例其他诊断(0.8%)(P < .001)。
  • 诊断BCC的比值比为32.0(96% CI, 9.9-103.2)。
  • MAY小球与组织学高危BCC诊断相关(比值比6.5;95% CI, 3.1-14.3)。
  • MAY小球从未见于浅表型BCC病例。

关键数值与推荐

  • MAY小球定义为偏振光和非偏振光下可见的聚集性黄白色结构。
  • MAY小球在BCC中阳性率21.0%,其他诊断中0.8%,P < .001。
  • MAY小球诊断BCC的比值比32.0(96% CI, 9.9-103.2)。
  • MAY小球与组织学高危BCC的比值比6.5(95% CI, 3.1-14.3)。

临床怎么用

  • 皮肤镜检查非色素性皮损时,发现MAY小球应高度怀疑BCC。
  • MAY小球提示可能为深部或组织学高危BCC亚型,而非浅表型。

局限性

  • 回顾性单中心设计可能限制普遍性。
  • MAY小球在BCC中敏感度较低(21.0%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Basal cell carcinoma (BCC) is the most common skin cancer. Dermoscopic imaging has improved diagnostic accuracy; however, diagnosis of nonpigmented BCC remains limited to arborizing vessels, ulceration, and shiny white structures. OBJECTIVE: To assess multiple aggregated yellow-white (MAY) globules as a diagnostic feature for BCC. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective, single-center, case-control study, nonpigmented skin tumors, determined clinically, were identified from a database of lesions consecutively biopsied during a 7-year period (January 1, 2009, to December 31, 2015). A subset of tumors was prospectively diagnosed, and reflectance confocal microscopy, optical coherence tomography, and histopathologic correlation were performed. Data analysis was conducted from July 1 to September 31, 2019. EXPOSURES: Investigators evaluated for the presence or absence of known dermoscopic criteria. MAY globules were defined as aggregated, white-yellow structures visualized in polarized and nonpolarized light. MAIN OUTCOMES AND MEASURES: The primary outcome was the diagnostic accuracy of MAY globules for the diagnosis of BCC. Secondary objectives included the association with BCC location and subtype. Interrater agreement was estimated. RESULTS: A total of 656 nonpigmented lesions from 643 patients (mean [SD] age, 63.1 [14.9] years; 381 [58.1%] male) were included. In all, 194 lesions (29.6%) were located on the head and neck. A total of 291 (44.4%) were BCCs. MAY globules were seen in 61 of 291 BCC cases (21.0%) and in 3 of 365 other diagnoses (0.8%) (P < .001). The odds ratio for diagnosis of BCC was 32.0 (96% CI, 9.9-103.2). The presence of MAY globules was associated with a diagnosis of histologic high-risk BCC (odds ratio, 6.5; 95% CI, 3.1-14.3). The structure was never seen in cases of superficial BCCs. CONCLUSIONS AND RELEVANCE: The findings suggest that MAY globules may have utility as a new BCC dermoscopic criterion with a high specificity. MAY globules were negatively associated with superficial BCC and positively associated with deeper-seated, histologic, higher-grade tumor subtypes.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Navarrete-Dechent C, Liopyris K, Rishpon A, et al. Association of Multiple Aggregated Yellow-White Globules With Nonpigmented Basal Cell Carcinoma. JAMA Dermatol. 2020. PMID: 32459294. doi:10.1001/jamadermatol.2020.1450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。